Sterigenics plans $410 million term loan for Nordion purchase

By Sara Rosenberg

New York, April 1 - Sterigenics has received a commitment for a $410 million term loan to help fund its acquisition of Nordion Inc., according to a 6-K filed late Monday with the Securities and Exchange Commission.

Credit Suisse Securities (USA) LLC, Goldman Sachs Bank USA and RBC Capital Markets LLC are the lead banks on the deal.

Other funds for the transaction will come from equity and cash on hand.

Under the agreement, Nordion is being purchased for $11.75 per share, or about $727 million.

Closing is expected in the second half of this year, subject to Nordion shareholder approval, receipt of regulatory approvals and other customary conditions.

Sterigenics is a Deerfield, Ill.-based sterilization services company. Nordion is an Ottawa-based health science company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.